Cargando…
Cancer Risk Following HLA-Incompatible Living Donor Kidney Transplantation
Incompatible living donor kidney transplant recipients (ILDKTr) require desensitization to facilitate transplantation, and this substantial upfront immunosuppression may result in serious complications, including cancer. METHODS. To characterize cancer risk in ILDKTr, we evaluated 858 ILDKTr and 12 ...
Autores principales: | Motter, Jennifer D., Massie, Allan B., Garonzik-Wang, Jacqueline M., Pfeiffer, Ruth M., Yu, Kelly J., Segev, Dorry L., Engels, Eric A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10365202/ https://www.ncbi.nlm.nih.gov/pubmed/37492080 http://dx.doi.org/10.1097/TXD.0000000000001505 |
Ejemplares similares
-
Patient and Graft Survival After A1/A2-incompatible Living Donor Kidney Transplantation
por: Bisen, Shivani S., et al.
Publicado: (2022) -
Kidney Transplantation Confers Survival Benefit for Candidates With Pulmonary Hypertension
por: Nguyen, Michelle C., et al.
Publicado: (2021) -
Transplantation Amid a Pandemic: The Fall and Rise of Kidney Transplantation in the United States
por: Bisen, Shivani S., et al.
Publicado: (2022) -
HLA Antibody Incompatible Renal Transplantation: Long-term Outcomes Similar to Deceased Donor Transplantation
por: Krishnan, Nithya, et al.
Publicado: (2021) -
The Tangible Benefits of Living Donation: Results of a Qualitative Study of Living Kidney Donors
por: Van Pilsum Rasmussen, Sarah E., et al.
Publicado: (2020)